May 23, 2019 / 6:26 AM / 4 months ago

Slovenian drugmaker Krka Q1 profit jumps by 42%

LJUBLJANA, May 23 (Reuters) - Slovenian generic drugs producer Krka made a group net profit of 70.3 million euros ($78.4 million) in the first quarter of 2019 versus 49.4 million euros in the same period last year, Krka said in a statement on Thursday.

It said sales rose to 378.5 million euros, up from 338 million a year ago.

$1 = 0.8969 euros Reporting by Marja Novak; Editing by Mark Potter

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below